PT87996A - Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de anormalidades em complexos imunologicos de circulacao e na funcao dos monocitos contendo arn de dupla cadeia - Google Patents

Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de anormalidades em complexos imunologicos de circulacao e na funcao dos monocitos contendo arn de dupla cadeia

Info

Publication number
PT87996A
PT87996A PT87996A PT8799688A PT87996A PT 87996 A PT87996 A PT 87996A PT 87996 A PT87996 A PT 87996A PT 8799688 A PT8799688 A PT 8799688A PT 87996 A PT87996 A PT 87996A
Authority
PT
Portugal
Prior art keywords
monochites
utical
abnormalities
circulation
correction
Prior art date
Application number
PT87996A
Other languages
English (en)
Other versions
PT87996B (pt
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of PT87996A publication Critical patent/PT87996A/pt
Publication of PT87996B publication Critical patent/PT87996B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
PT87996A 1987-07-17 1988-07-15 Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de anormalidades em complexos imunologicos de circulacao e na funcao dos monocitos contendo arn de dupla cadeia PT87996B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7461687A 1987-07-17 1987-07-17
US12457787A 1987-11-24 1987-11-24

Publications (2)

Publication Number Publication Date
PT87996A true PT87996A (pt) 1989-06-30
PT87996B PT87996B (pt) 1995-03-31

Family

ID=26755855

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87996A PT87996B (pt) 1987-07-17 1988-07-15 Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de anormalidades em complexos imunologicos de circulacao e na funcao dos monocitos contendo arn de dupla cadeia

Country Status (18)

Country Link
EP (1) EP0300680B1 (pt)
JP (1) JP2601520B2 (pt)
KR (1) KR0131880B1 (pt)
CN (1) CN1035050A (pt)
AT (1) ATE142500T1 (pt)
AU (2) AU1820588A (pt)
CA (1) CA1326999C (pt)
DE (1) DE3855527T2 (pt)
DK (1) DK399288A (pt)
ES (1) ES2093607T3 (pt)
FI (1) FI883352A (pt)
HU (1) HUT47432A (pt)
IE (1) IE76914B1 (pt)
IL (1) IL86862A (pt)
NO (1) NO175023C (pt)
NZ (1) NZ225310A (pt)
OA (1) OA08890A (pt)
PT (1) PT87996B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
BR9007741A (pt) * 1989-10-11 1992-08-11 Hem Res Inc Protecao contra estados de choque subsequentes a lesoes por rnas de duplo filamento
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
EP0596912A4 (en) * 1991-07-16 1994-07-27 Hem Pharma Corp Modulation and diagnosis of cytokine dysfunctions.
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
TW589189B (en) * 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CZ295108B6 (cs) 1998-03-20 2005-05-18 Benitec Australia Ltd Syntetický gen obsahující dispergovanou nebo cizorodou deoxyribonukleovou molekulu a genový konstrukt obsahující tento syntetický gen
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP2314700A1 (en) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
AU2005321940B2 (en) * 2004-12-29 2012-04-19 Mannkind Corporation Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
DE112016003047B4 (de) * 2015-11-17 2022-10-27 Highlight Therapeutics, S.L. Neue pharmazeutische zusammensetzung umfassend partikel umfassend einen komplex eines doppelsträngigen polyribonukleotids und eines polyalkylenimins
CN105434341B (zh) * 2015-12-22 2018-07-10 肇庆大华农生物药品有限公司 一种兽用聚腺尿苷酸注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
US4140761A (en) * 1977-04-11 1979-02-20 The United States Of America As Represented By The Department Of Health, Education & Welfare Modification of hepatitis B virus infection in chronic carriers of hepatitis B surface antigen
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
IL86862A (en) 1993-05-13
JPS6490126A (en) 1989-04-06
OA08890A (en) 1989-10-31
EP0300680A3 (en) 1991-06-19
EP0300680A2 (en) 1989-01-25
DK399288A (da) 1989-01-18
KR0131880B1 (ko) 1998-04-17
ATE142500T1 (de) 1996-09-15
IL86862A0 (en) 1988-11-30
NZ225310A (en) 1991-05-28
AU1820588A (en) 1989-01-19
HUT47432A (en) 1989-03-28
NO175023B (no) 1994-05-09
EP0300680B1 (en) 1996-09-11
IE881894L (en) 1989-01-17
FI883352A0 (fi) 1988-07-14
FI883352A (fi) 1989-01-18
AU1761195A (en) 1995-06-29
JP2601520B2 (ja) 1997-04-16
CN1035050A (zh) 1989-08-30
NO175023C (no) 1994-08-17
ES2093607T3 (es) 1997-01-01
DE3855527T2 (de) 1997-04-03
DE3855527D1 (de) 1996-10-17
NO882853L (no) 1989-01-18
KR890001580A (ko) 1989-03-27
PT87996B (pt) 1995-03-31
IE76914B1 (en) 1997-11-05
DK399288D0 (da) 1988-07-15
CA1326999C (en) 1994-02-15
NO882853D0 (no) 1988-06-28

Similar Documents

Publication Publication Date Title
PT87996A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de anormalidades em complexos imunologicos de circulacao e na funcao dos monocitos contendo arn de dupla cadeia
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
BR8300475A (pt) Composto, composicao farmaceutica, processo para tratamento de infeccao virotica em um animal de sangue quente ou de sangue frio, e processo para a preparacao de tal composto
ZA885192B (en) Pharmaceutical preparations
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
PT92174A (pt) Processo para aumentar a hemoglobina fetal mediante tratamento com actividade e/ou inibina
EP0306347A3 (en) Diagnosis and treatment of double-stranded rna deficiency states
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
BR9500436A (pt) Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico
ATE80039T1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
DE69018099D1 (de) Polyamin-Derivate als antineoplastische Mittel.
NO874241D0 (no) Terapeutisk aktive salter.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
KR880008812A (ko) 항균성 동결건조 제제
PT84658B (pt) Processo para a preparacao de derivados de naftiridina e piridopirazina substituidas com arilo
ATE105192T1 (de) Methode fuer die kontrolle von chronischer atmungskrankheit und nekrotischer enteritis bei voegeln.
ES2038702T3 (es) Un procedimiento para preparar derivados triazolopirimidina triciclicos.
YA et al. Clinical neurological and CT brain findings in children with beta-thalassemia major
IT1238210B (it) Esteri del cefamandolo nafato, procedimento per la loro preparazione erelative composizioni farmaceutiche.
IT9041714A0 (it) Linfa del libro dell'abete rosso (abies picea) per la cura di malattie neoplastiche e da virus in genere

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940907

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960331